img

Global Acquired Immunodeficiency Syndrome Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Acquired Immunodeficiency Syndrome Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Acquired immunodeficiency syndrome (AIDS) is one of the most widespread, catastrophic, and incurable diseases among humans in the world. According to a report published by the World Health Organization (WHO) in 2013, deaths caused by HIV ranked sixth in the total number of deaths in the world. Human immunodeficiency virus (HIV) presents itself as a complex mixture of symptoms, all related to severe immune compromise, while AIDS is an advanced stage of HIV infection.
Acquired Immunodeficiency Syndrome report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acquired Immunodeficiency Syndrome market is projected to reach US$ 1962.2 million in 2029, increasing from US$ 1536 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acquired Immunodeficiency Syndrome market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Takeda
AstraZeneca Eli Lilly and Company
Merck KGaA
Sanofi
Pfizer
Amgen
Biogen
Novartis
Actelion
Daiichi Sankyo Company
Segment by Type
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acquired Immunodeficiency Syndrome market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Acquired Immunodeficiency Syndrome introduction, etc. Acquired Immunodeficiency Syndrome Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Acquired Immunodeficiency Syndrome market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Acquired Immunodeficiency Syndrome
1.1 Acquired Immunodeficiency Syndrome Market Overview
1.1.1 Acquired Immunodeficiency Syndrome Product Scope
1.1.2 Acquired Immunodeficiency Syndrome Market Status and Outlook
1.2 Global Acquired Immunodeficiency Syndrome Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Acquired Immunodeficiency Syndrome Market Size by Region (2018-2029)
1.4 Global Acquired Immunodeficiency Syndrome Historic Market Size by Region (2018-2024)
1.5 Global Acquired Immunodeficiency Syndrome Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Acquired Immunodeficiency Syndrome Market Size (2018-2029)
1.6.1 North America Acquired Immunodeficiency Syndrome Market Size (2018-2029)
1.6.2 Europe Acquired Immunodeficiency Syndrome Market Size (2018-2029)
1.6.3 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size (2018-2029)
1.6.4 Latin America Acquired Immunodeficiency Syndrome Market Size (2018-2029)
1.6.5 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size (2018-2029)
2 Acquired Immunodeficiency Syndrome Market by Type
2.1 Introduction
2.1.1 Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
2.1.2 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
2.2 Global Acquired Immunodeficiency Syndrome Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Acquired Immunodeficiency Syndrome Historic Market Size by Type (2018-2024)
2.2.2 Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Acquired Immunodeficiency Syndrome Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Acquired Immunodeficiency Syndrome Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Acquired Immunodeficiency Syndrome Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Acquired Immunodeficiency Syndrome Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Acquired Immunodeficiency Syndrome Revenue Breakdown by Type (2018-2029)
3 Acquired Immunodeficiency Syndrome Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 Others
3.2 Global Acquired Immunodeficiency Syndrome Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Acquired Immunodeficiency Syndrome Historic Market Size by Application (2018-2024)
3.2.2 Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Acquired Immunodeficiency Syndrome Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Acquired Immunodeficiency Syndrome Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Acquired Immunodeficiency Syndrome Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Acquired Immunodeficiency Syndrome Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Acquired Immunodeficiency Syndrome Revenue Breakdown by Application (2018-2029)
4 Acquired Immunodeficiency Syndrome Competition Analysis by Players
4.1 Global Acquired Immunodeficiency Syndrome Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acquired Immunodeficiency Syndrome as of 2022)
4.3 Date of Key Players Enter into Acquired Immunodeficiency Syndrome Market
4.4 Global Top Players Acquired Immunodeficiency Syndrome Headquarters and Area Served
4.5 Key Players Acquired Immunodeficiency Syndrome Product Solution and Service
4.6 Competitive Status
4.6.1 Acquired Immunodeficiency Syndrome Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Takeda
5.1.1 Takeda Profile
5.1.2 Takeda Main Business
5.1.3 Takeda Acquired Immunodeficiency Syndrome Products, Services and Solutions
5.1.4 Takeda Acquired Immunodeficiency Syndrome Revenue (US$ Million) & (2018-2024)
5.1.5 Takeda Recent Developments
5.2 AstraZeneca Eli Lilly and Company
5.2.1 AstraZeneca Eli Lilly and Company Profile
5.2.2 AstraZeneca Eli Lilly and Company Main Business
5.2.3 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Products, Services and Solutions
5.2.4 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue (US$ Million) & (2018-2024)
5.2.5 AstraZeneca Eli Lilly and Company Recent Developments
5.3 Merck KGaA
5.3.1 Merck KGaA Profile
5.3.2 Merck KGaA Main Business
5.3.3 Merck KGaA Acquired Immunodeficiency Syndrome Products, Services and Solutions
5.3.4 Merck KGaA Acquired Immunodeficiency Syndrome Revenue (US$ Million) & (2018-2024)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi Acquired Immunodeficiency Syndrome Products, Services and Solutions
5.4.4 Sanofi Acquired Immunodeficiency Syndrome Revenue (US$ Million) & (2018-2024)
5.4.5 Sanofi Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Acquired Immunodeficiency Syndrome Products, Services and Solutions
5.5.4 Pfizer Acquired Immunodeficiency Syndrome Revenue (US$ Million) & (2018-2024)
5.5.5 Pfizer Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Acquired Immunodeficiency Syndrome Products, Services and Solutions
5.6.4 Amgen Acquired Immunodeficiency Syndrome Revenue (US$ Million) & (2018-2024)
5.6.5 Amgen Recent Developments
5.7 Biogen
5.7.1 Biogen Profile
5.7.2 Biogen Main Business
5.7.3 Biogen Acquired Immunodeficiency Syndrome Products, Services and Solutions
5.7.4 Biogen Acquired Immunodeficiency Syndrome Revenue (US$ Million) & (2018-2024)
5.7.5 Biogen Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Acquired Immunodeficiency Syndrome Products, Services and Solutions
5.8.4 Novartis Acquired Immunodeficiency Syndrome Revenue (US$ Million) & (2018-2024)
5.8.5 Novartis Recent Developments
5.9 Actelion
5.9.1 Actelion Profile
5.9.2 Actelion Main Business
5.9.3 Actelion Acquired Immunodeficiency Syndrome Products, Services and Solutions
5.9.4 Actelion Acquired Immunodeficiency Syndrome Revenue (US$ Million) & (2018-2024)
5.9.5 Actelion Recent Developments
5.10 Daiichi Sankyo Company
5.10.1 Daiichi Sankyo Company Profile
5.10.2 Daiichi Sankyo Company Main Business
5.10.3 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Products, Services and Solutions
5.10.4 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue (US$ Million) & (2018-2024)
5.10.5 Daiichi Sankyo Company Recent Developments
6 North America
6.1 North America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Acquired Immunodeficiency Syndrome Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Acquired Immunodeficiency Syndrome Market Dynamics
11.1 Acquired Immunodeficiency Syndrome Industry Trends
11.2 Acquired Immunodeficiency Syndrome Market Drivers
11.3 Acquired Immunodeficiency Syndrome Market Challenges
11.4 Acquired Immunodeficiency Syndrome Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Acquired Immunodeficiency Syndrome Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Acquired Immunodeficiency Syndrome Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Acquired Immunodeficiency Syndrome Market Size Share by Region (2018-2024)
Table 4. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Acquired Immunodeficiency Syndrome Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Acquired Immunodeficiency Syndrome Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Acquired Immunodeficiency Syndrome Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2018-2024)
Table 9. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2024-2029)
Table 11. North America Acquired Immunodeficiency Syndrome Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Acquired Immunodeficiency Syndrome Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Acquired Immunodeficiency Syndrome Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Acquired Immunodeficiency Syndrome Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Acquired Immunodeficiency Syndrome Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Acquired Immunodeficiency Syndrome Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Acquired Immunodeficiency Syndrome Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Acquired Immunodeficiency Syndrome Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Acquired Immunodeficiency Syndrome Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Acquired Immunodeficiency Syndrome Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Acquired Immunodeficiency Syndrome Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Acquired Immunodeficiency Syndrome Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2018-2024)
Table 24. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2024-2029)
Table 26. North America Acquired Immunodeficiency Syndrome Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Acquired Immunodeficiency Syndrome Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Acquired Immunodeficiency Syndrome Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Acquired Immunodeficiency Syndrome Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Acquired Immunodeficiency Syndrome Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Acquired Immunodeficiency Syndrome Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Acquired Immunodeficiency Syndrome Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Acquired Immunodeficiency Syndrome Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Acquired Immunodeficiency Syndrome Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Acquired Immunodeficiency Syndrome Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Acquired Immunodeficiency Syndrome Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acquired Immunodeficiency Syndrome as of 2022)
Table 39. Date of Key Players Enter into Acquired Immunodeficiency Syndrome Market
Table 40. Global Acquired Immunodeficiency Syndrome Key Players Headquarters and Area Served
Table 41. Acquired Immunodeficiency Syndrome Product Solution and Service
Table 42. Global Acquired Immunodeficiency Syndrome Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Takeda Basic Information List
Table 45. Takeda Description and Business Overview
Table 46. Takeda Acquired Immunodeficiency Syndrome Products, Services and Solutions
Table 47. Revenue (US$ Million) in Acquired Immunodeficiency Syndrome Business of Takeda (2018-2024)
Table 48. Takeda Recent Developments
Table 49. AstraZeneca Eli Lilly and Company Basic Information List
Table 50. AstraZeneca Eli Lilly and Company Description and Business Overview
Table 51. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Products, Services and Solutions
Table 52. Revenue (US$ Million) in Acquired Immunodeficiency Syndrome Business of AstraZeneca Eli Lilly and Company (2018-2024)
Table 53. AstraZeneca Eli Lilly and Company Recent Developments
Table 54. Merck KGaA Basic Information List
Table 55. Merck KGaA Description and Business Overview
Table 56. Merck KGaA Acquired Immunodeficiency Syndrome Products, Services and Solutions
Table 57. Revenue (US$ Million) in Acquired Immunodeficiency Syndrome Business of Merck KGaA (2018-2024)
Table 58. Merck KGaA Recent Developments
Table 59. Sanofi Basic Information List
Table 60. Sanofi Description and Business Overview
Table 61. Sanofi Acquired Immunodeficiency Syndrome Products, Services and Solutions
Table 62. Revenue (US$ Million) in Acquired Immunodeficiency Syndrome Business of Sanofi (2018-2024)
Table 63. Sanofi Recent Developments
Table 64. Pfizer Basic Information List
Table 65. Pfizer Description and Business Overview
Table 66. Pfizer Acquired Immunodeficiency Syndrome Products, Services and Solutions
Table 67. Revenue (US$ Million) in Acquired Immunodeficiency Syndrome Business of Pfizer (2018-2024)
Table 68. Pfizer Recent Developments
Table 69. Amgen Basic Information List
Table 70. Amgen Description and Business Overview
Table 71. Amgen Acquired Immunodeficiency Syndrome Products, Services and Solutions
Table 72. Revenue (US$ Million) in Acquired Immunodeficiency Syndrome Business of Amgen (2018-2024)
Table 73. Amgen Recent Developments
Table 74. Biogen Basic Information List
Table 75. Biogen Description and Business Overview
Table 76. Biogen Acquired Immunodeficiency Syndrome Products, Services and Solutions
Table 77. Revenue (US$ Million) in Acquired Immunodeficiency Syndrome Business of Biogen (2018-2024)
Table 78. Biogen Recent Developments
Table 79. Novartis Basic Information List
Table 80. Novartis Description and Business Overview
Table 81. Novartis Acquired Immunodeficiency Syndrome Products, Services and Solutions
Table 82. Revenue (US$ Million) in Acquired Immunodeficiency Syndrome Business of Novartis (2018-2024)
Table 83. Novartis Recent Developments
Table 84. Actelion Basic Information List
Table 85. Actelion Description and Business Overview
Table 86. Actelion Acquired Immunodeficiency Syndrome Products, Services and Solutions
Table 87. Revenue (US$ Million) in Acquired Immunodeficiency Syndrome Business of Actelion (2018-2024)
Table 88. Actelion Recent Developments
Table 89. Daiichi Sankyo Company Basic Information List
Table 90. Daiichi Sankyo Company Description and Business Overview
Table 91. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Products, Services and Solutions
Table 92. Revenue (US$ Million) in Acquired Immunodeficiency Syndrome Business of Daiichi Sankyo Company (2018-2024)
Table 93. Daiichi Sankyo Company Recent Developments
Table 94. North America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2024) & (US$ Million)
Table 95. North America Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 96. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2018-2024) & (US$ Million)
Table 97. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 98. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2018-2024) & (US$ Million)
Table 100. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2024-2029) & (US$ Million)
Table 101. Asia-Pacific Acquired Immunodeficiency Syndrome Market Share by Region (2018-2024)
Table 102. Asia-Pacific Acquired Immunodeficiency Syndrome Market Share by Region (2024-2029)
Table 103. Latin America Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2024) & (US$ Million)
Table 105. Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 106. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2018-2024) & (US$ Million)
Table 108. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 109. Acquired Immunodeficiency Syndrome Market Trends
Table 110. Acquired Immunodeficiency Syndrome Market Drivers
Table 111. Acquired Immunodeficiency Syndrome Market Challenges
Table 112. Acquired Immunodeficiency Syndrome Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acquired Immunodeficiency Syndrome Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Acquired Immunodeficiency Syndrome Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Acquired Immunodeficiency Syndrome Market Share by Regions: 2022 VS 2029
Figure 4. Global Acquired Immunodeficiency Syndrome Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Acquired Immunodeficiency Syndrome Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Acquired Immunodeficiency Syndrome Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Acquired Immunodeficiency Syndrome Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Figure 11. Global Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Figure 13. Global Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Acquired Immunodeficiency Syndrome Market Size Share by Type: 2022 & 2029
Figure 15. North America Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2018-2029)
Figure 16. Europe Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2018-2029)
Figure 20. Hospital Pharmacy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Retail Pharmacy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Global Acquired Immunodeficiency Syndrome Market Size Share by Application: 2022 & 2029
Figure 24. North America Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2018-2029)
Figure 25. Europe Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2018-2029)
Figure 26. Asia-Pacific Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2018-2029)
Figure 27. Latin America Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2018-2029)
Figure 28. Middle East and Africa Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2018-2029)
Figure 29. Acquired Immunodeficiency Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Acquired Immunodeficiency Syndrome Market Share in 2022
Figure 31. North America Acquired Immunodeficiency Syndrome Market Share by Country (2018-2029)
Figure 32. United States Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 33. Canada Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 34. Germany Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 35. France Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 36. U.K. Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 37. Italy Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 38. Russia Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific Acquired Immunodeficiency Syndrome Market Share by Region (2018-2029)
Figure 41. China Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 42. Japan Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 43. South Korea Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 45. India Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 46. Australia Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 47. Latin America Acquired Immunodeficiency Syndrome Market Share by Country (2018-2029)
Figure 48. Mexico Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 49. Brazil Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Country (2018-2029)
Figure 51. Turkey Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 53. UAE Acquired Immunodeficiency Syndrome Market Size (2018-2029) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries